Red Flags, Pitfalls, and Cautions in Y90 Radiotherapy

Area of Science:

• Interventional Radiology
• Hepatobiliary Malignancy Management
• Nuclear Medicine

Background:

• Radioembolization with yttrium-90 (Y90) microspheres is a growing treatment modality for palliative care in liver-dominant cancers.
• This outpatient procedure demonstrates efficacy with a favorable toxicity profile when patients are carefully selected.

Purpose of the Study:

• To review practical considerations for implementing Y90 radioembolization in daily clinical practice.
• To guide Interventional Radiologists in managing complex patient scenarios and optimizing treatment strategies.

Main Methods:

• Review of common clinical scenarios encountered in Y90 radioembolization.
• Discussion on evaluating liver function, prior therapies, and patient performance status.
• Emphasis on integrating Y90 with systemic therapy, considering retreatment, and utilizing c-arm CT for watershed zone tumor evaluation.

Main Results:

• Y90 radioembolization requires careful consideration of multiple patient-specific variables for successful palliation.
• Optimal treatment planning involves assessing liver function, previous treatments, systemic therapy, performance status, and tumor location.

Conclusions:

• Individualized assessment of diverse clinical factors is crucial for developing a comprehensive Y90 radioembolization treatment plan.
• Thorough evaluation ensures maximal treatment response and clear communication of expected outcomes and toxicities to patients.